GOCH, GERMANY/CUDDALORE, INDIA: DMV-Fonterra Excipients will acquire the business and assets of Brahmar Cellulose Pvt Ltd (BCPL) producer of pharmaceutical microcrystalline cellulose (MCC) and sodium carboxyl methyl cellulose (SCMC) based in Cuddalore, India. The acquisition, which is subject to approvals from Indian government authorities, is scheduled to be completed in the fourth quarter of 2011.
The acquisition will create a unique market position for DMV-Fonterra Excipients as the sole manufacturer and supplier of the most commonly used diluents and superdisintegrants to the pharmaceutical industry. This, in turn, will improve the company’s ability to support its customers with reducing their supply chain and formulation costs by having a consistent, single source and single quality framework across their key products.
“The acquisition of Brahmar Cellulose is a further step in achieving our ambition to become a leading supplier in pharmaceutical excipients and will give a stronger base for future developments in this area,” said Jan Jongsma, CEO at DMV-Fonterra Excipients.
Long-term synergies will be achieved by combining DMV-Fonterra Excipient’s current global market position and sales network with Brahmar Cellulose extensive product knowledge on MCC and SCMC and market position in India. DMV-Fonterra Excipients has an established global sales network which will be able to incorporate Brahmar Cellulose product range. DMV-Fonterra Excipients will leverage its current quality and regulation framework and reputation to serve all levels of the pharmaceutical market.
© WOC News